Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Conference Proceeding
|
Abstracts of “Institute for Research and Medical Consultations (IRMC) - Summer Research Program – 2020” presented at Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia, on November 18, 2020Saudi journal of medicine and medical sciences, 2021, Vol.9 (1), p.91-112 [Peer Reviewed Journal]Copyright: © 2020 Saudi Journal of Medicine & Medical Sciences 2020 ;ISSN: 1658-631X ;EISSN: 2321-4856Full text available |
|
2 |
Material Type: Conference Proceeding
|
Possible Utilization of Personal Data and Medical Care in Japan, Focusing on Japan’s Act on Anonymously Processed Medical Information to Contribute to Medical Research and DevelopmentIFIP Advances in Information and Communication Technology, 2022, Vol.AICT-656, p.67-85Attribution ;ISBN: 9783031156878 ;ISBN: 3031156870 ;DOI: 10.1007/978-3-031-15688-5_7Digital Resources/Online E-Resources |
|
3 |
Material Type: Conference Proceeding
|
P154/193 Impact of stent-retriever tip design on distal embolization during mechanical thrombectomy: a randomized in vitro evaluationJournal of neurointerventional surgery, 2023, Vol.15 (Suppl 2), p.A74-A74 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1759-8478 ;EISSN: 1759-8486 ;DOI: 10.1136/jnis-2023-ESMINT.182Full text available |
|
4 |
Material Type: Conference Proceeding
|
Medical radionuclide research activities at JRC-GeelEPJ Web of conferences, 2024, Vol.292, p.12001 [Peer Reviewed Journal]EISSN: 2100-014X ;DOI: 10.1051/epjconf/202429212001Full text available |
|
5 |
Material Type: Conference Proceeding
|
35752 Ultrasound vs fluoroscopy in the management of cervical radicular pain: can we replace fluoroscopy?Regional anesthesia and pain medicine, 2023, Vol.48 (Suppl 1), p.A211-A211 [Peer Reviewed Journal]2023 American Society of Regional Anesthesia & Pain Medicine 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1098-7339 ;EISSN: 1532-8651 ;DOI: 10.1136/rapm-2023-ESRA.387Full text available |
|
6 |
Material Type: Conference Proceeding
|
CASFM: Exploring cohesion and mission in the formation of a Medical Education Research Group (MERG)Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4853Full text available |
|
7 |
Material Type: Conference Proceeding
|
731 Characterization of platinum resistance status by WGCNA co-expression modules in ovarian carcinoma patientsInternational journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A304-A304 [Peer Reviewed Journal]2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-ESGO.635Full text available |
|
8 |
Material Type: Conference Proceeding
|
A New Challenge to Research Ethics: Patients-Led Research (PLR) and the Role of Internet Based Social NetworksTransforming Healthcare with the Internet of Things, 2016, Vol.221, p.36-40 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;DOI: 10.3233/978-1-61499-633-0-36 ;PMID: 27071872Digital Resources/Online E-Resources |
|
9 |
Material Type: Conference Proceeding
|
Proceedings of Peer-reviewed and selected articles from Turgut Ozal University Faculty of Medicine 7th International Student CongressClinical and investigative medicine, 2016, Vol.39 (6), p.27491-27491 [Peer Reviewed Journal]EISSN: 1488-2353 ;PMID: 27917782Full text available |
|
10 |
Material Type: Conference Proceeding
|
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancerInternational journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A56-A56 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.101Full text available |
|
11 |
Material Type: Conference Proceeding
|
490 National cancer research institute (NCRI) survey of hormone replacement therapyprescribing in gynaecological and breast cancer survivors and in women who have had risk-reducing oophorectomy in the United KingdomInternational journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A357-A357 [Peer Reviewed Journal]2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-ESGO.756Full text available |
|
12 |
Material Type: Conference Proceeding
|
From biomedical research to viable products on the health care market - a North Sweden model called CMTFIFMBE Proceedings, 2009, p.127-130Springer-Verlag Berlin Heidelberg 2009 ;ISSN: 1680-0737 ;ISBN: 3642038921 ;ISBN: 9783642038921 ;ISBN: 9783642038938 ;ISBN: 364203893X ;EISSN: 1433-9277 ;EISBN: 9783642038938 ;EISBN: 364203893X ;DOI: 10.1007/978-3-642-03893-8_36Full text available |
|
13 |
Material Type: Conference Proceeding
|
Pharm. D. pathways to biomedical research: the National Institutes of Health special conference on pharmacy researchPharmacotherapy, 2008, Vol.28 (7), p.821-833 [Peer Reviewed Journal]ISSN: 0277-0008 ;EISSN: 1875-9114 ;DOI: 10.1592/phco.28.7.821 ;PMID: 18576897Full text available |
|
14 |
Material Type: Conference Proceeding
|
Metabonomics research accelerates discovery of medical biomarkersE3S Web of Conferences, 2021, Vol.245, p.3048 [Peer Reviewed Journal]2021. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2267-1242 ;ISSN: 2555-0403 ;EISSN: 2267-1242 ;DOI: 10.1051/e3sconf/202124503048Full text available |
|
15 |
Material Type: Conference Proceeding
|
OP98 Associations between adherence to cancer prevention recommendations and risk of cancer: a cohort study within the UK BiobankJournal of epidemiology and community health (1979), 2023, Vol.77 (Suppl 1), p.A48-A49 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0143-005X ;EISSN: 1470-2738 ;DOI: 10.1136/jech-2023-SSMabstracts.97Full text available |
|
16 |
Material Type: Conference Proceeding
|
O33 Qualitative story completion: an innovative method with exciting potential for health researchBMJ open, 2019, Vol.9 (Suppl 1), p.A13-A13 [Peer Reviewed Journal]2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.33Full text available |
|
17 |
Material Type: Conference Proceeding
|
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignanciesJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A783-A783 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0750Full text available |
|
18 |
Material Type: Conference Proceeding
|
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWIBMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.52 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.52Full text available |
|
19 |
Material Type: Conference Proceeding
|
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencingJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1320-A1321 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1272Full text available |
|
20 |
Material Type: Conference Proceeding
|
364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 studyInternational journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A70-A71 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.124Full text available |